NCT06907550View on ClinicalTrials.gov

Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting With Symptoms of Endometriosis

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions

Endometriosis

Interventions

DIAGNOSTIC_TEST

The Mitomic Endometriosis Test (MET) blood test for early detection of endometriosis

Patients will complete a questionnaire about their endometriosis symptoms and a sample of blood will be taken prior to their laparoscopy and sent to the laboratory for testing.

Trial Locations (1)

23219

Pearsanta, Inc., Richmond

All Listed Sponsors

lead

Pearsanta, Inc

INDUSTRY

NCT06907550 - Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting With Symptoms of Endometriosis | Biotech Hunter | Biotech Hunter